Holmium laser resection of the prostate is more cost effective than transurethral resection of the prostate: results of a randomized prospective study

Objectives. A cost-effectiveness analysis was carried out comparing electrosurgical transurethral resection of the prostate (TURP) with holmium:yttrium-aluminum-garnet laser resection of the prostate (HoLRP). Methods. One hundred twenty patients with benign prostatic hyperplasia and urodynamically p...

Full description

Saved in:
Bibliographic Details
Published in:Urology (Ridgewood, N.J.) N.J.), 2001-03, Vol.57 (3), p.454-458
Main Authors: Fraundorfer, Mark R, Gilling, Peter J, Kennett, Katie M, Dunton, Neville G
Format: Article
Language:English
Subjects:
Aged
Biological and medical sciences
Cost-Benefit Analysis
Diseases of the urinary system
Holmium
Humans
Laser Therapy - economics
Laser Therapy - methods
Male
Medical sciences
Methods
Nephrology. Urinary tract diseases
New Zealand
Prostate - surgery
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Time Factors
Transurethral Resection of Prostate - economics
Transurethral Resection of Prostate - methods
Tumors of the urinary system
Urethral Obstruction - surgery
Urinary tract. Prostate gland
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives. A cost-effectiveness analysis was carried out comparing electrosurgical transurethral resection of the prostate (TURP) with holmium:yttrium-aluminum-garnet laser resection of the prostate (HoLRP). Methods. One hundred twenty patients with benign prostatic hyperplasia and urodynamically proved obstruction were randomized to undergo either TURP or HoLRP. Economic and clinical outcome data were recorded prospectively out to 1 year postoperatively. Results. The HoLRP group experienced fewer complications and had a shorter hospital stay and catheterization time than the TURP group, with equivalent clinical outcomes at 12 months. HoLRP cost 24.5% less (New Zealand dollars $651) than TURP during the first year. Conclusions. Because the clinical outcomes out to 1 year were equivalent, HoLRP was more cost-effective than TURP. On the basis of these savings, a minimum of 93 cases per year are required to recover the capital and service costs of the holmium:yttrium-aluminum-garnet laser.
ISSN:0090-4295
1527-9995
DOI:10.1016/S0090-4295(00)00987-0